e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Exploring molecular mechanisms of allergy and asthma in animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2014 abstract - A20 levels in dendritic cells control eosinophilic versus neutrophilic lung inflammation in asthma
H. Vroman, I. M. Bergen, G. van Loo, R. W. Hendriks, B. N. Lambrecht, B. van den Blink, M. Kool (Rotterdam, Netherlands; Zwijnaarde, Ghent, Belgium)
Source:
International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Session:
Exploring molecular mechanisms of allergy and asthma in animal models
Session type:
Oral Presentation
Number:
3234
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Vroman, I. M. Bergen, G. van Loo, R. W. Hendriks, B. N. Lambrecht, B. van den Blink, M. Kool (Rotterdam, Netherlands; Zwijnaarde, Ghent, Belgium). LSC 2014 abstract - A20 levels in dendritic cells control eosinophilic versus neutrophilic lung inflammation in asthma. Eur Respir J 2014; 44: Suppl. 58, 3234
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic
Source: Annual Congress 2013 –Asthma
Year: 2013
Young Investigator session: A20 levels in dendritic cells control eosinophilic versus neutrophilic lung inflammation in asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
Increased influx of progenitor B cell subsets in the lung with diverse levels of
in-situ
proliferation and activation in a murine model of allergic inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
LSC 2014 abstract - RORgamma t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Eosinophilic airway inflammation is associated with increased TLR2 and TLR4 expression in adult asthmatics
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
LSC 2014 abstract - Influence of a Th2 immune response on airway remodeling in asthma
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
Chymase-positive mast cells represent a major source for IL-17A in airway inflammation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Aspirin hypersensitive and aspirin-tolerant eosinophilic asthma share common patern of inflammatory cells influx and lipid mediators in airways
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
HMGB1 expression and function in the allergic airway immune response
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Mapping of eosinophil and basophils in COPD lung tissues
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Imbalance of pro-inflammatory and anti-inflammatory markers on circulating dendritic cells in COPD
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Heterogeneous levels of CD86+CD209+ and CD83+CD209+ dendritic cells in patients with different severity of bronchial asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
MIP-1β is associated with eosinophilic airway inflammation
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept